Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma - Wikidata - awgldk - TriplyDB

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

http://www.wikidata.org/entity/Q37237431

about

Lymphoma Immunotherapy: Current Status Profile of Ronald Levy. Interview by Phillip Downey Active idiotypic vaccination versus control immunotherapy for follicular lymphoma Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice Strategies for cancer vaccine development.Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.Anti-idiotypic Fab Fragments Image a Conserved N-terminal Epitope Patch of Grass Pollen Allergen Phl p 1 Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.Haematological malignancies: at the forefront of immunotherapeutic innovation.A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy Adoptive T-cell therapy for B-cell malignancies.Biology and treatment of follicular lymphoma.Prognostic tools in follicular lymphomas.Idiotype vaccines for lymphoma therapy.Vaccination strategies in lymphomas and leukaemias: recent progress.Managing newly diagnosed follicular lymphoma: state of the art and future perspectives.Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma.The promise of the anti-idiotype concept.Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance.Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen

P2860

Q26782902-AF28771D-9843-44E0-A3A2-4BB3D3B080C5 Q28314974-1BF345C5-2ABF-444F-8741-369D060E11EC Q33691505-45B91F17-D40E-4F5E-85BF-37D6FFF81EA1 Q33989839-597271B9-0D5F-47C5-939E-A8290271BBC4 Q34038338-451A43DF-5E29-46D7-8220-7FC9D88F7C8D Q34093532-3CDFA666-12CC-416E-8CF0-1B451D17510B Q34154260-D7127EDA-0F60-43D3-B1E7-8A1FCB0A81BC Q35096289-676126E6-B223-49B8-BBA3-5F77F24DED22 Q35880618-2483E6F3-4A0D-4E79-94F3-91552A17B4FD Q36221727-6D8FBCF4-5DDA-4AB9-B070-715752B4BF7E Q36386109-EA17103E-E24B-40AA-A8E8-437DADB08BDE Q37427993-E500ED19-A2A7-49E6-9BFE-762361D0F90B Q37810116-2AD402EC-CEC9-4ED4-9156-4B361AD78897 Q37810118-7F06142E-4F7C-4878-ABAF-C415F4A38413 Q37810119-18C0B2FA-1F75-4D27-8119-CDD452AAF80A Q37892587-ED53C7F2-FA7D-4256-AF01-1D99E1B4BC22 Q37929157-7F855B5B-2264-4E6D-8F3E-17FE1B15B1D5 Q38088002-41D88D48-A1F2-42F1-8223-F4A11670738F Q38174058-B3D45161-79D8-4286-B864-5FB558CE12A0 Q42032055-E9D3A691-FFE4-43F1-B7C2-A79ECE80767D Q42215347-0D574435-0E47-4AD9-A247-57B325E12A46 Q42419120-FFC3AA20-E820-49FB-A8F0-17068F8CCF94 Q47217201-C9059431-D414-4A35-B9DD-E490A4C301C7 Q58547013-92CAA4EB-A5D3-4137-A711-62B67A88939F

P2860

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

http://www.wikidata.org/entity/Q37237431

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-idiotype antibody respons ...... urvival in follicular lymphoma

@en

Anti-idiotype antibody respons ...... rvival in follicular lymphoma.

@nl

type

label

Anti-idiotype antibody respons ...... urvival in follicular lymphoma

@en

Anti-idiotype antibody respons ...... rvival in follicular lymphoma.

@nl

prefLabel

Anti-idiotype antibody respons ...... urvival in follicular lymphoma

@en

Anti-idiotype antibody respons ...... rvival in follicular lymphoma.

@nl

P1433

Q37237431-11073148-0CFA-450E-BA42-A8209C75DA59

P1476

Q37237431-040BBC79-B050-4B23-AFBC-32D2288CA546

P2093

Q37237431-39963B33-6192-4F9D-A42D-D4FFFECB51C9

Q37237431-57ECDCEE-6B84-430E-B81A-97E42AB46611

Q37237431-8F64B0E5-0B42-4D35-BA29-D42A95D2CC70

Q37237431-F18BB11E-1818-45E4-83A3-082796EC71E1

P2860

Q37237431-00C23A24-0B0E-442E-9902-7E8315451F61

Q37237431-035D70D6-4988-4FEA-B305-06E0248E45C0

Q37237431-0BEC45FD-3F07-4E4D-9D1D-741969224DBA

Q37237431-0EEF3F82-9CA1-4AE1-B494-720E96B1CC81

Q37237431-24F1F4AE-4936-41AF-AA4F-4F6EE439EADF

Q37237431-39A97981-661F-4FBE-A22E-4DD87FB26CBD

Q37237431-3C1D5D81-4783-4BD0-AA9E-3F61F7C16906

Q37237431-5105B2E2-2706-4D86-B8BE-F8E3F961C064

Q37237431-55841748-9D48-4529-A662-97B0E786EDC5

Q37237431-6AAEF39D-5EB8-4ACA-8F70-4F8CA5110C47

P304

Q37237431-97D9ADF2-BCD1-4BCF-A331-DAF11BE263BB

P31

Q37237431-DF2A92C7-4CC4-466A-9EDE-BBA2491DEA9C

P356

Q37237431-B046BB59-CED6-4138-AC32-4AA321933FDA

P407

Q37237431-B6478EEA-7699-4853-9C16-50313B4CF939

P433

Q37237431-F1D5FCA1-61EF-4389-AFE0-FF759C1BE165

P478

Q37237431-7A60D37C-46FE-4798-969A-607A2C2A1863

P50

Q37237431-5BAEC9E4-BB8D-43A0-8E6A-4A191F466C1D

P577

Q37237431-419C9A28-311F-4FB4-8652-60C066B48717

P5875

Q37237431-9225E287-8B41-4B8C-B86F-77ADD5A9E495

P698

Q37237431-76EB2A2E-48C1-496D-9A62-78A76FB1E524

P921

Q37237431-496576F0-FB79-4700-886B-2C7BBA8662A8

P932

Q37237431-559F7E40-86C2-4A16-A817-EFFC46356B53

P356

BLOOD-2009-01-201988

P1433

P1476

Anti-idiotype antibody respons ...... urvival in follicular lymphoma

@en

P2093

Behnaz Taidi

http://www.w3.org/2001/XMLSchema#string

Debra Czerwinski

http://www.w3.org/2001/XMLSchema#string

Ronald Levy

http://www.w3.org/2001/XMLSchema#string

Weiyun Z Ai

http://www.w3.org/2001/XMLSchema#string

P2860

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy.

Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.

Follicular lymphoma: clinical features and treatment.

Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.

Mouse x human heterohybridomas as fusion partners with human B cell tumors.

P304

5743-5746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-01-201988

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Robert Tibshirani

P577

2009-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24257839

http://www.w3.org/2001/XMLSchema#string

P698

19346494

http://www.w3.org/2001/XMLSchema#string

P921

P932

2700314

http://www.w3.org/2001/XMLSchema#string